News - Anti-virals, Rest of the World


Popular Filters

One in five South African health care centers experience ARV stock shortages


South Africa’s Treatment Action Campaign (TAC) has warned that the country’s HIV treatment program…

Anti-viralsHealthcarePharmaceuticalProductionRest of the WorldSouth Africa

Deal worth $156m to provide HIV drugs for Africa


The Global Fund to Fight AIDS, tuberculosis and malaria has signed a $156 million grant agreement with…

Anti-viralsHealthcarePharmaceuticalRest of the World

Campaign group's concern at blocks on India's generic exports


An HIV and AIDS campaigner has written an open letter to the US government in protest at what it calls…

Anti-viralsBayerGenericsHealthcareNatco PharmaRest of the WorldSorafenib

Switzerland's Lonza involvement in South Africa pharma project in doubt


The South Africa government is expected to publish a request for information from potential international,…

Anti-viralsGenericsLonzaNovartisProductionRest of the World

Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar


USA-based generic drugmaker Mylan (Nasdaq: MYL) says that it has delivered, through its South African-based…

AmgenAnti-Arthritics/RheumaticsAnti-viralsAsia-PacificBiotechnologyCiplaEnbrelEtaceptGenericsMarkets & MarketingMylan LaboratoriesPfizerRest of the World

Mylan debuts HIV/AIDS drug portfolio in South Africa


US generics company Mylan (Nasdaq: MYL) says that its subsidiary in South Africa has launched a comprehensive…

Anti-viralsGenericsMarkets & MarketingMylan LaboratoriesRest of the World

Indian drugmakers show interest in investing in Zimbabwe


Owen Mugurungi, director of the Aids and TB Unit in Zimbabwe's Ministry of Health Child and Welfare,…

Anti-viralsAsia-PacificGenericsProductionRest of the World

Consumer groups call for fixed-dose HIV drugs in South African tenders


Consumer groups Treatment Action Campaign and Medecins sans Frontiers have issued a call for the inclusion…

Anti-viralsGenericsHealthcareMarkets & MarketingPharmaceuticalPricingRest of the World

Merck & Co in-licenses Chimerix antiviral; Fiocruz to make ARVs in Africa


USA-based Chimerix, a venture-funded biotech focused on developing novel oral antivirals, has announced…

Anti-viralsChimerixCMX001CMX157FiocruzGlobalLicensingMarkets & MarketingMerck & CoPharmaceuticalRest of the World

Teva gets rights to BioAlliance's Sitavig in Israel


French drugmaker BioAlliance Pharma (Euronext Paris: BIO) has signed an exclusive license agreement for…

Anti-viralsBioAlliance PharmaLicensingPharmaceuticalRest of the WorldSitavigTeva Pharmaceutical Industries

Tanzanian drugmaker to start producing ARVs in August


Tanzania Pharmaceutical Industries (TPI) was due to start productions earlier this year, but finalization…

Anti-viralsGenericsMarkets & MarketingPharmaceuticalRest of the WorldTanzania Pharma Industries

New pharma plant in Tanzania to produce ARVs


Tanzania will start the first domestic commercial production of antiretroviral (ARV) drugs in the next…

Anti-viralsGenericsMarkets & MarketingRest of the World

New low cost HIV drug to be made by Ugandan company


Starting as early as next month, Uganda will produce a new low cost and more effective life saving HIV/AIDS…

Anti-viralsGenericsMarkets & MarketingRest of the WorldTenofovir Disoproxil Fumarate

South Africa debuts new five-year HIV and tuberculosis plan


Coinciding with Worlds AIDS day last week, the South African government launched its new national strategic…

Anti-viralsHealthcarePharmaceuticalRespiratory and PulmonaryRest of the World

Kenya gets $345 million from Global Fund for HIV/AIDS fight


Over the next few weeks, Kenya will be signing a $345 million grant agreement with the Global Fund to…

Anti-viralsFinancialHealthcarePharmaceuticalRest of the World

ViiV Healthcare announces 16 new grantees for 2011/2012 to prevent mother-to-child HIV transmission


ViiV Healthcare, the HIV/AIDS joint venture of UK drugs giant GlaxoSmithKline (LSE: GSK) and US behemoth…

Anti-viralsFinancialGlaxoSmithKlineHealthcarePfizerPharmaceuticalRest of the WorldViiV Healthcare

EU launches development and cooperation projects with South Africa, including AIDS and TB


European Development Commissioner Andris Piebalgs is visiting South Africa from September 13 to 16 to…

Anti-viralsAntibiotics and Infectious diseasesEuropeFinancialHealthcarePharmaceuticalRest of the World

Sub-Saharan group says legal and policy barriers to HIV should be confronted


In Sub-Saharan Africa, the region most heavily affected by HIV, legal, policy and social barriers, including…

Anti-viralsLegalPharmaceuticalPoliticsRest of the World

Back to top